FY2024 recorded revenue of RM813.70 million compared to RM704.73 million in FY2023, a growth of 15.5% Profit before tax and profit after tax for FY2024 increased 26.5% and 19.0% respectively year-on-year Duopharma Biotech announces 30.4% increase in total dividend for FY2024 compared to FY2023 Group revenue improves driven by…Read More

You might also be interested in reading How Web3 Marketing Changes the Game.